Assessing Frailty in Elderly Patients Who Have Ischemic Heart Disease
FRAIL_HEART
Assessment of Frailty in Elderly People With Ischemic Heart Disease Being Considered for Revascularisation.
1 other identifier
observational
150
1 country
1
Brief Summary
Participants aged 80 years or over, who attend Castle Hill Hospital with either stable angina or an acute coronary syndrome will be invited to participate in the study. After induction into the study, these participants will be assessed for frailty and quality of life (QoL) using predetermined assessment tools. Quality of life (QoL) will be assessed using the standardised SF-12 questionnaire proforma. Frailty assessment will be based on the use of the Fried Frailty Phenotype criteria and the Edmonton Frailty Scale. Patients will be reassessed at 3,9 and 24 months for their clinical outcomes, repeat frailty assessment and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 11, 2016
CompletedFirst Posted
Study publicly available on registry
July 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedApril 4, 2022
April 1, 2022
3.9 years
October 11, 2016
April 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Quality Of Life Questionnaire
The primary out come will be quality of life assessed by SF-12 survey forms
baseline and 3, 9 and 24 months
Secondary Outcomes (5)
Change in frailty Status - Fried frailty Criteria
baseline and 3, 9 and 24 months
Change in frailty Status - Edmonton Frailty Score
baseline and 3, 9 and 24 months
Major adverse clinical events during hospitalization
baseline and 3, 9 and 24 months
Major Adverse Clinical Event
24 months
Predictors of adverse outcome
baseline and 3, 9 and 24 months
Study Arms (1)
Frailty status
Frailty status will be determined by prespecified assessment tools in the study protocol. These assessment tools will be Fried Frailty phenotype model and edmonton frailty Scale.
Eligibility Criteria
All patients (male and female) aged 80 and over and who have a primary diagnosis of ischaemic heart disease will be eligible for participation in the study.
You may qualify if:
- Aged 80 years and above and either
- Have been seen in the cardiology out-patient department with a diagnosis of stable angina
- Have been admitted to Castle Hill Hospital with non-ST elevation acute myocardial infarction (NSTEMI)
- Have been admitted to Castle Hill Hospital with ST-elevation acute myocardial infarction (STEMI)
- Have been referred to Castle Hill Hospital for coronary angioplasty
- Have been referred to Castle Hill Hospital for coronary artery bypass graft surgery
You may not qualify if:
- Patients will be excluded from the study in the event of any of the following:
- Patients who are unable to provide informed consent including those with advanced dementia.
- Patients, who are not able to speak good English sufficiently to be able to understand the study information, give consent and complete study measures.
- Patients who have a primary diagnosis of significant valvular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Castle Hill Hospital
Cottingham, East Riding of Yorkshire NHS Trust, HU16 5JQ, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Angela Hoye, MB.ChB,PhD
Hull and East Yorkshire NHS Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2016
First Posted
July 15, 2019
Study Start
July 1, 2016
Primary Completion
June 1, 2020
Study Completion
December 1, 2020
Last Updated
April 4, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share
individual participant data will not be shared